US 10117944
Targeted therapeutics
granted A61KA61K31/365A61K31/395
Quick answer
US patent 10117944 (Targeted therapeutics) held by Madrigal Pharmaceuticals, Inc. expires Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Madrigal Pharmaceuticals, Inc.
- Grant date
- Tue Nov 06 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 01 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/365, A61K31/395, A61K31/436, A61K31/56